FibroBiologics (FBLG)

• Market cap: $6.04M
• 1 day: -6.45%
• 5 days: -18.88%
• 1 month: -17.14%
• 3 months: -76.94%
• 6 months: -83.75%
• Year to date: -75.83%
• 1 year: -93.14%
• 5 years: -99.8%
• 10 years: -99.8%
• Sector: Healthcare
• Industry: Biotechnology

About: FibroBiologics Inc a clinical-stage biotechnology company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with unmet medical needs, including wound healing, multiple sclerosis, or MS, degenerative disc disease, psoriasis, certain cancers, and potential human longevity applications including thymic involution reversal using a thymic organoid. Its product candidates are CYWC628, CYPS317, CYMS101 and CybroCell.

Employees: 15